Haemonetics Corp
(NYSE:HAE)
$90.09
-1.72[-1.87%]
Last update: 7:00PM (Delayed 15-Minutes)
Get Real Time Here
$90.07
-0.0200[-0.02%]
Open91.290Close90.090
Vol / Avg.312.087K / 285.015KMkt Cap4.569B
Day Range89.120 - 91.29052 Wk Range71.760 - 95.260

Haemonetics Stock (NYSE:HAE), Key Statistics

Haemonetics Stock (NYSE: HAE) analysis, key statistics.

Valuation Measures
Enterprise Value
5.1B
Trailing P/E
34.52
Forward P/E
22.12
PE Ratio (TTM)
34.59
PEG Ratio (TTM)
2.21
Price / Sales (ttm)
3.87
Price / Book (mrq)
5.38
Price / EBITDA
17.28
Enterprise Value / EBITDA (TTM)
18.82
Earnings Yield
2.9%
Price change 1 M
1.02
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
17.05
Tangible Book value per share
2.57
Total Liabilities (Quarterly)
1.1B
Total Assets
2B
Total Liabilities
- -
Profitability
Net income Growth
1.06
Gross Margin
53.73%
Net Margin
13.18%
EBIT Margin
17.24%
EBITDA Margin
24.63%
Operating Margin
17.24%

Haemonetics Stock (NYSE:HAE), Key Statistics

Haemonetics Stock (NYSE: HAE) analysis, key statistics.

Valuation Measures
Enterprise Value
5.1B
Trailing P/E
34.52
Forward P/E
22.12
PE Ratio (TTM)
34.59
PEG Ratio (TTM)
2.21
Price / Sales (ttm)
3.87
Price / Book (mrq)
5.38
Price / EBITDA
17.28
Enterprise Value / EBITDA (TTM)
18.82
Earnings Yield
2.9%
Price change 1 M
1.02
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
17.05
Tangible Book value per share
2.57
Total Liabilities (Quarterly)
1.1B
Total Assets
2B
Total Liabilities
- -
Profitability
Net income Growth
1.06
Gross Margin
53.73%
Net Margin
13.18%
EBIT Margin
17.24%
EBITDA Margin
24.63%
Operating Margin
17.24%

Haemonetics Stock (NYSE:HAE), Key Statistics

Haemonetics Stock (NYSE: HAE) analysis, key statistics.

Valuation Measures
Enterprise Value
5.1B
Trailing P/E
34.52
Forward P/E
22.12
PE Ratio (TTM)
34.59
PEG Ratio (TTM)
2.21
Price / Sales (ttm)
3.87
Price / Book (mrq)
5.38
Price / EBITDA
17.28
Enterprise Value / EBITDA (TTM)
18.82
Earnings Yield
2.9%
Price change 1 M
1.02
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
17.05
Tangible Book value per share
2.57
Total Liabilities (Quarterly)
1.1B
Total Assets
2B
Total Liabilities
- -
Profitability
Net income Growth
1.06
Gross Margin
53.73%
Net Margin
13.18%
EBIT Margin
17.24%
EBITDA Margin
24.63%
Operating Margin
17.24%

Haemonetics Stock (NYSE:HAE), Key Statistics

Haemonetics Stock (NYSE: HAE) analysis, key statistics.

Valuation Measures
Enterprise Value
5.1B
Trailing P/E
34.52
Forward P/E
22.12
PE Ratio (TTM)
34.59
PEG Ratio (TTM)
2.21
Price / Sales (ttm)
3.87
Price / Book (mrq)
5.38
Price / EBITDA
17.28
Enterprise Value / EBITDA (TTM)
18.82
Earnings Yield
2.9%
Price change 1 M
1.02
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
17.05
Tangible Book value per share
2.57
Total Liabilities (Quarterly)
1.1B
Total Assets
2B
Total Liabilities
- -
Profitability
Net income Growth
1.06
Gross Margin
53.73%
Net Margin
13.18%
EBIT Margin
17.24%
EBITDA Margin
24.63%
Operating Margin
17.24%

Haemonetics Stock (NYSE:HAE), Key Statistics

Haemonetics Stock (NYSE: HAE) analysis, key statistics.

Valuation Measures
Enterprise Value
5.1B
Trailing P/E
34.52
Forward P/E
22.12
PE Ratio (TTM)
34.59
PEG Ratio (TTM)
2.21
Price / Sales (ttm)
3.87
Price / Book (mrq)
5.38
Price / EBITDA
17.28
Enterprise Value / EBITDA (TTM)
18.82
Earnings Yield
2.9%
Price change 1 M
1.02
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
17.05
Tangible Book value per share
2.57
Total Liabilities (Quarterly)
1.1B
Total Assets
2B
Total Liabilities
- -
Profitability
Net income Growth
1.06
Gross Margin
53.73%
Net Margin
13.18%
EBIT Margin
17.24%
EBITDA Margin
24.63%
Operating Margin
17.24%

Haemonetics Stock (NYSE:HAE), Key Statistics

Haemonetics Stock (NYSE: HAE) analysis, key statistics.

Valuation Measures
Enterprise Value
5.1B
Trailing P/E
34.52
Forward P/E
22.12
PE Ratio (TTM)
34.59
PEG Ratio (TTM)
2.21
Price / Sales (ttm)
3.87
Price / Book (mrq)
5.38
Price / EBITDA
17.28
Enterprise Value / EBITDA (TTM)
18.82
Earnings Yield
2.9%
Price change 1 M
1.02
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
17.05
Tangible Book value per share
2.57
Total Liabilities (Quarterly)
1.1B
Total Assets
2B
Total Liabilities
- -
Profitability
Net income Growth
1.06
Gross Margin
53.73%
Net Margin
13.18%
EBIT Margin
17.24%
EBITDA Margin
24.63%
Operating Margin
17.24%

Haemonetics Stock (NYSE:HAE), Key Statistics

Haemonetics Stock (NYSE: HAE) analysis, key statistics.

Valuation Measures
Enterprise Value
5.1B
Trailing P/E
34.52
Forward P/E
22.12
PE Ratio (TTM)
34.59
PEG Ratio (TTM)
2.21
Price / Sales (ttm)
3.87
Price / Book (mrq)
5.38
Price / EBITDA
17.28
Enterprise Value / EBITDA (TTM)
18.82
Earnings Yield
2.9%
Price change 1 M
1.02
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
17.05
Tangible Book value per share
2.57
Total Liabilities (Quarterly)
1.1B
Total Assets
2B
Total Liabilities
- -
Profitability
Net income Growth
1.06
Gross Margin
53.73%
Net Margin
13.18%
EBIT Margin
17.24%
EBITDA Margin
24.63%
Operating Margin
17.24%

Haemonetics Stock (NYSE:HAE), Key Statistics

Haemonetics Stock (NYSE: HAE) analysis, key statistics.

Valuation Measures
Enterprise Value
5.1B
Trailing P/E
34.52
Forward P/E
22.12
PE Ratio (TTM)
34.59
PEG Ratio (TTM)
2.21
Price / Sales (ttm)
3.87
Price / Book (mrq)
5.38
Price / EBITDA
17.28
Enterprise Value / EBITDA (TTM)
18.82
Earnings Yield
2.9%
Price change 1 M
1.02
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
17.05
Tangible Book value per share
2.57
Total Liabilities (Quarterly)
1.1B
Total Assets
2B
Total Liabilities
- -
Profitability
Net income Growth
1.06
Gross Margin
53.73%
Net Margin
13.18%
EBIT Margin
17.24%
EBITDA Margin
24.63%
Operating Margin
17.24%

Haemonetics Stock (NYSE:HAE), Key Statistics

Haemonetics Stock (NYSE: HAE) analysis, key statistics.

Valuation Measures
Enterprise Value
5.1B
Trailing P/E
34.52
Forward P/E
22.12
PE Ratio (TTM)
34.59
PEG Ratio (TTM)
2.21
Price / Sales (ttm)
3.87
Price / Book (mrq)
5.38
Price / EBITDA
17.28
Enterprise Value / EBITDA (TTM)
18.82
Earnings Yield
2.9%
Price change 1 M
1.02
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
17.05
Tangible Book value per share
2.57
Total Liabilities (Quarterly)
1.1B
Total Assets
2B
Total Liabilities
- -
Profitability
Net income Growth
1.06
Gross Margin
53.73%
Net Margin
13.18%
EBIT Margin
17.24%
EBITDA Margin
24.63%
Operating Margin
17.24%

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2023 Benzinga | All Rights Reserved